Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer patients. By combining tumor marker readings with patients' genetic ...

Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

Cancer is an umbrella term used to characterize the abnormal growth of cells in different organs and tissues. Specific cancer types are named and categorized commonly based on location, mutation, and ...

Researchers show that obesity alters pancreatic cells to produce cholecystokinin, which drives cancer growth, revealing new ...

A 69 year old female patient with cancer in the head (widest part) of the pancreas spreading to a major abdominal artery (left image). After combined chemotherapy and radiation treatment, the tumor ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Development and prospective validation of a novel cfDNA-based diagnostic model for the early detection of pancreatic cancer. Five-year outcomes of perioperative or only adjuvant gemcitabine plus ...

The Tumor Marker Gene Model (TMGM) is a diagnostic tool to determine if patients with pancreatic cancer are suited for post-treatment surgery. It determines how a patient’s DNA affects their tumor ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Doctors and scientists have struggled for many years to find effective treatments for it. Many patients are diagnosed at a ...